Top View
- Clinically Relevant Concentrations of Anticancer Drugs: a Guide for Nonclinical Studies Dane R
- PDF-Document
- Retinoids (Acitretin, Adapalene, Alitretinoin, Bexarotene, Isotretinoin, Tazarotene and Tretinoin) – Update on Teratogenicity and Neuropsychiatric Disorders
- Targretin, Bexarotene, Belongs to a Group of Medicines Known As Retinoids, Which Are Related to Vitamin A
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- Principles of Antineoplastic Therapy
- Targeting TR4 Nuclear Receptor with Antagonist Bexarotene Increases
- Prevents and Overcomes Acquired Paclitaxel (Taxol) Resistance in Human Non–Small Cell Lung Cancer
- Acitretin, Adapalene, Alitretinoin, Bexarotene, Isotretinoin, Tretinoin and Tazarotene) Œ Update on Teratogenicity and Neuropsychiatric Disorders
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- Istodax Prior Authorization Request Form
- Direct Binding of Arsenic Trioxide to AMPK and Generation of Inhibitory Effects on Acute Myeloid Leukemia Precursors Elspeth M
- Early Stage Treatment Options Theresa Pacheco, Md
- Alitretinoin for the Treatment of Chronic Hand Eczema: Clinical Rationale
- Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy
- Synergistic Effect of a Retinoid X Receptor-Selective Ligand Bexarotene and Docetaxel in Prostate Cancer
- Photodegradation of Bexarotene and Its Implication for Cytotoxicity
- 2713-5, 25 Mitomycin C
- Systematic Development of Small Molecules to Inhibit Specific Microscopic Steps of Aβ42 Aggregation in Alzheimer’S Disease
- Targretin, INN-Bexarotene
- Current Evidence and Applications of Photodynamic Therapy in Dermatology Part 1: Cutaneous Neoplasms
- Aminolevulinic Acid and Phototoxicity
- Bexarotene (Targretin) Reference Number: ERX.SPMN.120 Effective Date: 03/14 Revision Log Last Review Date: 09/16
- Open Full Page
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
- Anticancer Drugs Repurposed for Alzheimer's Disease: a Systematic
- [2016]. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
- Bexarotene) Sean Deangelo1* , Kailyn I
- Drug Delivery from Rapid Gelling Polymer
- Cutaneous T-Cell Lymphoma
- University of Cincinnati
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug Administration Approval
- Bexarotene (Targretin)
- Do Not Tube List
- Potential Interactions Between Antineoplastics and Antiretrovirals
- Endogenous and Combination Retinoids Are Active In
- Arsenic (Trioxide)
- Tamibarotene: a Candidate Retinoid Drug for Alzheimer's Disease
- The Retinoic Acid Receptor (RAR) Α-Specific Agonist Am80
- Supplementary Online Content
- Hazardous Drug List
- Acitretin, Adapalene, Alitretinoin, Bexarotene, Isotretinoin, Tretinoin
- Medications That Are Considered Hazardous
- Managing Pharmacotherapy in People Living with HIV And
- Targretin® (Bexarotene) Capsules, 75 Mg